Joaquin Duato is Chairman and Chief Executive Officer (CEO) of Johnson & Johnson, most diversified healthcare products company. Under his leadership, focused on tackling the toughest health challenges by developing innovative medicines and medtech solutions.
Under Joaquin’s leadership, J&J is accelerate healthcare innovation using data science and the latest technology to create breakthroughs in care, from cell therapy to robotic-assisted surgery.
Past of Joaquin Duato:
Before becoming CEO in January 2022 and Chairman in January 2023, Joaquin served as Vice Chairman of the Executive Committee, where he led the company’s pharmaceutical and consumer health businesses, as well as technology and global supply chain teams.
Over three decades with the company, working across multiple geographies, functions, and business segments, Joaquin developed a deep understanding of the unique role J&J serves in solving patients’ health challenges.
Study of Joaquin Duato:
A dual citizen of the U.S. and Spain, Joaquin Duato earned an MBA from ESADE in Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona.
CEO contact information
| CEO Full Name | Joaquin Duato |
| Company name | Johnson & Johnson |
| CEO Email Address | jduato@jnj.com |
| Phone number | +1732 524-0400 |
| Location | High Wycombe, HP12 4DP, United Kingdom |
Johnson & Johnson Executive Team
- Vanessa Broadhurst – Executive Vice President, Global Corporate Affairs
- Peter Fasolo, Ph.D. – Chief Human Resources Officer
- Liz Forminard – Executive Vice President, General Counsel
- William N. Hait – Chief External Innovation and Medical Officer
- Tim Schmid – Executive Vice President, Worldwide Chairman, MedTech
- James Swanson – Chief Information Officer
- Jennifer L. Taubert – Executive Vice President, Worldwide Chairman, Innovative Medicine
| Name | |
| Alex Gorsky – Former Chairman and Chief Executive Officer | agorsky@its.jnj.com |
| Joseph J. Wolk – Executive Vice President, Chief Financial Officer | jwolk@jnj.com |
| Kathryn E. Wengel – Chief Technical Operations & Risk Officer | kwengel@jnj.com |
Social media
| @Joaquin Duato | |
| N/A | |
| N/A | |
| N/A | |
| Website | jnj.com |
About Company
Johnson & Johnson is an American multinational, pharmaceutical and medical technologies corporation. It is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.
It was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.
J&J CEO Joaquin Duato Net Worth
The estimated net worth of Joaquin Duato is at least $72.1 Million dollars as of 2024. He is the Vice Chair, Exec Committee of Johnson & Johnson and owns about 94,191 shares of JNJ stock worth over $15 Million.
Joaquin is also the Director of Hess Corp and owns about 4,060 shares of Hess Corp (HES) stock worth over $589,999. Details can be seen in Joaquin Duato’s Latest Holdings Summary section.
Joaquin has made over 19 trades of the Johnson & Johnson stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 3,470 units of JNJ stock worth $558,601 on 13 February 2024.
Read Also: Thermo Fisher CEO Email